Prosecution Insights
Last updated: October 01, 2026
Application No. 18/687,565

CURABLE SILICONE COMPOSITION, CURED OBJECT THEREFROM, AND METHOD FOR PRODUCING SAID CURED OBJECT

Non-Final OA §112
Filed
Feb 28, 2024
Priority
Aug 31, 2021 — JP 2021-140800 +1 more
Examiner
ZIMMER, MARC S
Art Unit
Tech Center
Assignee
DuPont Toray Specialty Materials K.K.
OA Round
1 (Non-Final)
79%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allowance Rate
1251 granted / 1576 resolved
+19.4% vs TC avg
Strong +16% interview lift
Without
With
+16.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
41 currently pending
Career history
1607
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
40.1%
+0.1% vs TC avg
§102
25.7%
-14.3% vs TC avg
§112
24.3%
-15.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1576 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the A Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-18 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Applicants characterize the filler component (D) as “functional” without indicating what is the intended meaning of this term. It is appreciated, for instance, that at least several metal(loid) oxide fillers are contemplated and these may be thought of as inherently “functional” insofar as they contain a significant concentration of metal(loid)-OH groups. There are, at the same time, a number of possibilities such as the metal fine powders for which there are no obvious functional (groups). It is also possible that the functionality is provided by a treating agent that is reacted with the filler to impart compatibility/for coupling purposes. It will be necessary that Applicant clarify in what sense that the filler is “functional”. As an aside, the Specification characterizes the filler as organic in some parts of the disclosure and inorganic elsewhere. While there are mentioned some fillers that would indeed be regarded as organic, acrylonitrile/butadiene rubber particles for instance, the majority of the fillers mentioned are inorganic in nature and, therefore, the Examiner might surmise that Applicant had meant to recite inorganic filler. (To be clear, this doesn’t constitute a basis for rejection. Rather, the Examiner merely means to bring this to Applicants’ attention for further consideration.) Allowable Subject Matter Claims 1-18 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. The prior art contains a number of disclosures teachings organosiloxane compositions in possession of hot melt characteristics that contain an alkenyl-functional silicone resin, organohydrogensiloxane, hydrosilylation catalyst, and a filler. Each of these has, however, one or more shortcomings where meeting each of the limitations of the prior art is concerned. The most common deficiency of the references is a failure to teach a resin containing a corresponding fraction of D (R2SiO2/2) repeat units. In most instances, the references taught resins completely devoid of D units, such as MViTQ resins and, on the occasion that a MDT resin was taught, the D units contained alkenyl substituents, which claim 1 expressly excludes. Others also failed to teach an amount of filler consistent with that claimed. Among the references teachings most similar to that which is claimed, but not representing an obstacle to patentability include U.S. Patent Application Publication Nos. 2022/0032469, 2019/0169398, 2018/0105692, 2022/0169894, 2017/0355804, and 20140175488. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MARC S ZIMMER whose telephone number is (571)272-1096. The examiner can normally be reached M-F 8:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. September 4, 2026 /MARC S ZIMMER/Primary Patent Examiner, Art Unit 1765
Read full office action

Prosecution Timeline

Feb 28, 2024
Application Filed
Sep 10, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12747323
MIXTURE OF POLYMERIC ALKYL SILICATES
2y 11m to grant Granted Sep 29, 2026
Patent 12742109
SILOXANE COMPOUND AND FORMULATIONS COMPRISING SAID COMPOUND
3y 7m to grant Granted Sep 22, 2026
Patent 12742056
Curable Polymer Compositions Comprising Heteroatom-Containing Silane Compounds
2y 1m to grant Granted Sep 22, 2026
Patent 12734270
PROCESS FOR THE PRODUCTION OF BIODEGRADABLE SUPERABSORBENT POLYMER WITH HIGH ABSORBENCY UNDER LOAD BASED ON STYRENE MALEIC ACID COPOLYMERS AND BIOPOLYMER
1y 11m to grant Granted Sep 15, 2026
Patent 12729296
POLYPROPYLENE BLEND
3y 2m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
79%
Grant Probability
96%
With Interview (+16.2%)
2y 5m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1576 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month